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Ioana A. Cristea
Babes-Bolyai University and University of PisaPersonalized medicine is aimed at identifying which
characteristics of an individual predict the outcome of a
specific treatment, in order to get a better match between the
individual and the treatment received. We conducted a
systematic review and meta-analysis of randomized trials
comparing two psychotherapies directly in a group of
depressed patients with a specific characteristic. We focused
on the six most examined types of psychotherapy for adult
depression. Our searches resulted in 41 studies with 2,741
patientswhomet inclusion criteria. These 41 studies examined
27 specific characteristics of patients. Power calculations
indicated that we would need 4 studies for each characteristic
to find a clinically relevant effect size set at g = 0.50 and 16
studies for an effect size of 0.24. Only 3 patient characteristics
were found to have sufficient power and to significantly
moderate treatment outcomes. Cognitive-behavioral therapy
was found to be more effective than other therapies in older
adults (g= 0.29), in patientswith comorbid addictive disordersAddress correspondence to Pim Cuijpers, Ph.D., Department of
Clinical Psychology,VUUniversityAmsterdam,VanderBoechorststraat
1, 1081 BT Amsterdam, The Netherlands; e-mail: p.cuijpers@vu.nl.
0005-7894/© 2016Association for Behavioral andCognitive Therapies. Published
by Elsevier Ltd. All rights reserved.(g = 0.31), and in university students (g = 0.46). Risk of
bias was considerable in most of the included studies. It was
estimated that it will take another 326 years to have sufficient
statistical power for showing an effect size of g = 0.50 of the
27 characteristics, and 1,372 years to show an effect size
of 0.24. Although several dozens of studies have compared
the effects of psychotherapies in specific target groups, we will
need to develop more powerful alternatives to comparative
outcome studies in order to identify personalized treatments
for depression.
Keywords: personalized medicine; depression; psychotherapy; meta-
analysis; cognitive-behavioral therapy
SEVERAL EARLY PAPERS IN Behavior Therapy have
focused on the issue of personalizing psychological
treatments formental health problems. Brownell and
Wadden (1991) proposed a three-stage model for
identifying the best treatment for an individual with
obesity and Sobell and Sobell (1973) developed
a personalized treatment for people with alcohol-
related problems in the context of a randomized trial.
Although it has been recognized in the psychother-
apy field for a long time that outcome research
should not only focus on the effects of treatments, but
967per sonal i zed therapy for depre s s ionalso on “which treatment, bywhom, ismost effective
for this individual with that specific problem and
under which set of circumstances” (Paul, 1967),
personalized treatments have recently received much
interest from researchers in health care in general
(Katsanis, Javitt, & Hudson, 2008; Topol & Lauer,
2003). From that perspective, both articles in
Behavior Therapy were far ahead of their time and
provide perspectives on personalized treatments that
are still highly relevant. In this paper, we build on
these early studies and focus on the development of
personalized treatments of depression using meta-
analytic techniques.
It is well established that psychotherapies are
effective in the treatment of depression, including
cognitive-behavioral therapy (CBT; Churchill et al.,
2001; Cuijpers et al., 2013), interpersonal psycho-
therapy (IPT; Cuijpers et al., 2011), problem-
solving therapy (PST; Cuijpers, van Straten, &
Warmerdam, 2007; Malouff, Thorsteinsson, &
Schutte, 2007), behavioral activation (Ekers et al.,
2014), and most likely psychodynamic therapies
(Driessen et al., 2010; Leichsenring & Rabung,
2008). Although this has not been confirmed in
all studies (Tolin, 2010), several dozens of trials
directly comparing different types of psychotherapy
have also shown that there are no or only minor
differences in effects among these therapies and that
all bona fide therapies seem to be equally effective or
about equally effective in the treatment of depression
(Barth et al., 2013; Cuijpers, 2014; Cuijpers, van
Straten, Andersson, & van Oppen, 2008).
Although these therapies are effective in the
treatment of depression, there is also much room
for improvement. Modeling studies have shown that
treatments for depression can reduce the disease
burden of depression by only about 33% (Andrews,
Issakidis, Sanderson, Corry, & Lapsley, 2004). More
than 40% of the patients do not or only partially
respond to treatment and less than one third of all
patients are completely recovered after treatment
(Hollon et al., 2002). Relapse rates are estimated to
be 54% after 2 years and up to 85% within 15 years
after recovery from an initial episode (Vittengl, Clark,
Dunn, & Jarrett, 2007). Therefore, it is very im-
portant to improve the outcomes of treatment.
Personalized treatments are considered by many
to be one of the major ways to improve outcomes
of treatments in health care in general (Katsanis
et al., 2008; Topol & Lauer, 2003), including
mental health care (Cuijpers, Reynolds, Donker,
Andersson, & Beekman, 2012; Schneider, Arch,
& Wolitzky-Taylor, 2015; Simon & Perlis, 2010).
“Personalized medicine” aims at identifying which
characteristics of an individual predict the outcome
of a specific treatment in order to get a better matchbetween the individual and the treatment received
(Cuijpers, 2014; Cuijpers et al., 2012; Simon &
Perlis, 2010). These characteristics may include
sociodemographic characteristics, patient prefer-
ences, and clinical characteristics of the depressive
disorder, as well as biological markers. In the treat-
ment of depression, personalized treatments are
especially important because at this moment there is
very little evidence that, on average, one treatment
of depression is more effective than other treat-
ments (Cuijpers, 2014).
In recent years, several approaches have attempted
to develop personalized treatments in the field of
mental health. Studies in the fields of pharmacoge-
netics, genomics, proteomics, metabolomics, neuro-
imaging, and neuroendocrinology have not yet led
to effective personalized treatments (Cuijpers, 2014),
but it could be that combining these techniques
may lead in the longer term to successful therapies.
New data mining techniques are now emerging that
may also constitute a new approach to personalized
treatments, and clinical staging has also been pro-
posed as a model for personalized treatments of
depression (Jain, Hunter, Brooks,& Leuchter, 2013;
Rabinoff, Kitchen, Cook, & Leuchter, 2011; Riedel
et al., 2011).
In order to provide personalized treatments for
depression, we must identify characteristics of indi-
viduals that reliably predict differences in benefits
and/or adverse effects of alternative depression treat-
ments (Simon & Perlis, 2010). Two study designs
examining specific patient characteristics could pro-
duce the evidence needed to personalize treatment
selection (Simon & Perlis, 2010). In the first design,
two treatments are compared in an unselected group
of participants, and the researchers examine whether
a specific characteristic of the participants moderates
the relationship between treatment type and out-
come (Kraemer, Wilson, Fairburn, & Agras, 2002).
For example, in the NIMH Treatment of Depression
Collaborative Research Program it was found that
severity of depression at baseline significantly
predicted differential treatment effects (Elkin et al.,
1995). Pharmacotherapy appeared to be more
effective than psychotherapy in the more severely
depressed patients, while there was no difference
between pharmacotherapy and psychotherapies
in the less severely depressed. The disadvantage of
these studies is that they were not designed to exam-
ine moderators and usually did not have enough
statistical power to identify them (Brookes et al.,
2004). If significant moderators are identified in
such trials, this therefore always has to be confirmed
in new randomized trials in which patients with
this characteristic are randomized to the alternative
therapies.
968 cu i j p er s e t al .In the second type of research a group of patients
with a specific characteristic is selected, and they
are randomized to alternative treatments. For ex-
ample, in a study of patients with multiple sclerosis
it was found that CBT was more effective than
supportive-expressive group therapy (Mohr,
Boudewyn, Goodkin, Bostrom, & Epstein, 2001).
In the current paper, we present the results of a
systematic review of trials of this second type of
trials, in which depressed patients with a specific
characteristic are randomized to alternative psy-
chological treatments in order to investigate if they
respond differentially to different psychotherapies.
It is important to note that if a study does not
include a direct comparisonof alternative treatments,
it is not possible to identify moderators or predictors
of differential treatment response (Simon & Perlis,
2010). So, only studies in which two or more treat-
ments are directly compared with each other can be
used to examine moderators of treatments and will
be included in the current systematic review.
Method
identification and selection of studies
A database of 1,756 papers on the psychological
treatment of depression was used. This database
has been described in detail elsewhere (Cuijpers, van
Straten, Warmerdam, & Andersson, 2008), and
has been used in a series of earlier published meta-
analyses (www.evidencebasedpsychotherapies.org).
The database is continuously updated and was
developed through a comprehensive literature search
(from January 1966 to January 2015) in which
16,365 abstracts in PubMed (4,007 abstracts),
PsycINFO(3,147), Embase (5,912), and theCochrane
Central Register of Controlled Trials (3,995) were
examined. These abstracts were identified by combin-
ing terms indicative of psychological treatment and
depression (both medical subject heading terms and
text words). For this database, the primary studies
from earlier meta-analyses of psychological treatment
for depression were also checked to ensure that no
published studies had been missed.
We included randomized trials on short-term or
acute treatment of depression in which the effects
of two types of the psychotherapy were directly
compared with each other. From these trials we
selected those that were aimed at a specific target
group, meaning not an unselected group of adults
with depression. We tried to be as broad as possible
to define specific target groups, because any char-
acteristic that predicts a better outcome is relevant
for personalized treatments. There were no specific
theoretically based or empirically derived reasons
to select these target groups, but we selected these
characteristics because there were enough clinicaltrials available examining them. In the selection of
target groups, we built on previous meta-analyses
of the literature in which we explored relevant
subgroups of studies (Barth et al., 2013; Cuijpers,
Van Straten, Warmerdam, & Smits, 2008). These
specific target groups can be defined according to
a predefined sociodemographic characteristic (such
as older adults or minority groups), specific types of
depression (such as dysthymia, chronic depression,
or postnatal depression), and comorbid (mental or
somatic) conditions.
We included studies in which one of six types of
psychotherapy for adult depression were compared
with another psychotherapy: (a) CBT (a therapy
in which the therapist focuses on the impact that
a patient’s present dysfunctional thoughts affect
current behavior and functioning), (b) PST (a
psychological intervention that included at least
the following elements: definition of personal prob-
lems, generation of multiple solutions to each prob-
lem, selection of the best solution, the working out
of a systematic plan for this solution, and evalua-
tion as to whether the solution has resolved the
problem), (c) nondirective supportive counseling
(NDST; any unstructured therapy without specific
psychological techniques other than those common
to all approaches, such as helping people to ven-
tilate their experiences and emotions, and offering
empathy), (d) IPT (highly structured manual-based
psychotherapy that addresses interpersonal issues
in depression to the exclusion of all other foci of
clinical attention), (e) behavioral activation therapy
without cognitive restructuring (an intervention to
be an activity scheduled when the registration of
pleasant activities and the increase of positive inter-
actions between a person and his or her environ-
ment were the core elements of the treatment),
and (f) psychodynamic therapy (a therapy with the
primary objective of enhancing the patient’s under-
standing, awareness, and insight about repetitive
intrapsychic and intrapersonal conflicts). Extended
definitions of each of these therapies are given in
another paper (Cuijpers, van Straten, Andersson,
et al., 2008). We selected these types of therapy
because we knew from previous meta-analytic
research that these are the most examined types of
psychotherapy in depression (Cuijpers, van Straten,
Andersson, et al., 2008). We excluded trials in
which two therapies of the same type were com-
pared with each other (e.g., when these therapies
were offered in two different formats, like individ-
ual vs. telephone-administered therapy, or when a
therapy was compared with the same therapy while
one component was added or removed).
The other psychotherapy (that was compared
with one of these six major categories of therapy)
969per sonal i zed therapy for depre s s iondid not necessarily have to belong to one of these
categories as well. We included studies in which
depression was defined according to a diagnostic
interview in which a depressive disorder was
established, but we also included studies in which
participants had to score above a cutoff on a self-
rating depression scale for inclusion in the study.
We excluded studies on inpatients and on chil-
dren and adolescents below 18 years of age. Only
studies in English, German, Spanish, and Dutch
were included.
risk of bias assessment
We assessed the risk of bias of the studies according
to four basic criteria suggested by the Cochrane
Handbook for Systematic Reviews of Interventions
(Higgins & Green, 2011): adequate sequence gen-
eration (the randomization scheme was generated
correctly, like with a random numbers table or a
computerized random number generator); alloca-
tion to conditions by an independent (third) party
who was not involved in the trial; blinding of asses-
sors of outcomes; and completeness of follow-up
data (all randomized participants were included in
the analyses). Data extraction was conducted by
two independent researchers.
meta-analyses
We conducted separate analyses for each of the six
types of psychotherapy. For each comparison we
calculated the effect size indicating the difference
between the two treatments at posttest, adjusted for
small sample bias (Hedges’s g; Hedges & Olkin,
1985). Effect sizes were calculated by subtracting
(at posttest) the average score of the first treatment
from the average score of the second treatment,
and dividing the result by the pooled standard
deviations of the two groups. We used only those
instruments that explicitly measured symptoms of
depression, such as the Beck Depression Inventory
(BDI; Beck, Ward, Mendelson, Mock, & Erbaugh,
1961) or the Hamilton Rating Scale for Depression
(HRSD; Hamilton, 1960). If more than one depres-
sion measure was used, the mean of the effect sizes
was calculated (according to the methods described
in Borenstein, Hedges, Higgins, & Rothstein [2009];
assuming a correlation of r = 1), so that each study
provided only one effect size.
For each of the six types of psychotherapy, we
calculated effect sizes for each study in which a
specific target group was examined. We used the
computer program Comprehensive Meta-Analysis
(version 2.2.021) to calculate pooled mean effect
sizes. As we expected considerable heterogeneity,
we decided to calculate mean effect sizes using arandom effects model. In all analyses we calculated
the I2 statistic as an indicator of heterogeneity in
percentages (25% indicates low, 50%moderate, and
75%high heterogeneity; Higgins, Thompson, Deeks,
& Altman, 2003). We calculated 95% confidence
intervals (CI) around I2 (Ioannidis, Patsopoulos,
& Evangelou, 2007), using the noncentral chi–
squared-based approach within the heterogi module
for Stata (Orsini, Bottai, Higgins, & Buchan, 2006).
power calculations
Because we examined six types of psychotherapy,
and wanted to examine separate effect sizes for
specific target groups (with a specific sociodemo-
graphic characteristic, type of depression, comorbid
disorder, setting), we expected that for most com-
parisons insufficient statistical power was available
to find clinically relevant effect sizes. Therefore, we
conducted a power calculation for each comparison
we examined.
For each comparison, we calculated how many
studies are needed to have sufficient statistical
power for finding an effect size of g = 0.50. Effect
sizes of 0.50 and above have been defined as a
threshold for clinical significance in several studies
(Fournier et al., 2010; Kirsch et al., 2008; National
Institute for Health and Clinical Excellence, 2009).
Because the threshold of g = 0.50 for clinical
relevance has been criticized (Cuijpers, Turner,
Koole, van Dijke, & Smit, 2014; Moncrieff &
Kirsch, 2015), we also calculated the number of
studies that are needed to calculate a more con-
servative estimate of a clinically relevant effect size
based on the “minimally important difference.”
This has been estimated to be g = 0.24 (Cuijpers
et al., 2014).
For each comparison, we calculated the mean
number of participants in each treatment condition.
Then we calculated how many studies with this
number of participants would be needed to find
an effect size of g = 0.50 or g = 0.24. The power
calculations were conducted according to the proce-
dures suggested by Borenstein et al. (2009). In these
calculations we conservatively assumed a medium
level of between-study variance (τ2 = 0.67); a sta-
tistical power of 0.80; and a significance level, alpha,
of .05.
Because we calculated the number of studies
needed to show significant effect sizes of 0.50 and
0.24, we were also able to calculate what percent-
age of the studies would be needed to find that these
effect sizes have actually been conducted. This gives
an indication of how many studies still have to be
conducted in order to find significant effect sizes of
g = 0.50 and g = 0.24 for each of the examined
characteristics.
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selection and inclusion of studies
After examining a total of 16,365 abstracts (12,196
after removal of duplicates), we retrieved 1,756
full-text papers for further consideration. We ex-
cluded 1,715 of the retrieved papers. The reasons
for excluding studies are given in Figure 1. Forty-
one studies met inclusion criteria. Figure 1 presents
a flowchart describing the inclusion process.
characteristics of included studies
Selected characteristics of the included studies are
presented in Table 1. In the 41 included studies,
a total of 2,741 patients participated (978 in the
NDST, 812 in CBT, 226 in PST, 221 in behavioral
activation therapy, 91 in IPT, 70 in psychodynamic
therapy, and 343 in other therapies). In the 41
studies a total of 91 psychotherapy conditions wereFIGURE 1 Flowchart ofincluded (27 NDST, 25 CBT, 9 behavioral activa-
tion, 8 PST, 5 IPT, 5 psychodynamic therapy, and
12 other therapies). The average number of patients
per condition was 30. A total of 27 specific target
groups were included in the studies (Table 1).risk of bias
The risk of bias in most of the studies was con-
siderable. Twelve of the 41 studies reported an
adequate sequence generation (29%),while the other
29 did not report a sequence generation method.
Eight studies reported allocation to conditions by
an independent (third) party (20%). Twenty studies
reported using blinded outcome assessors (49%),
and 7 used only self-report outcomes, the others did
not report blinding of assessors. In 17 studies intent-
to-treat analyses (completeness of follow-up data)
were conducted (41%). Only 2 studies (5%) met allinclusion of studies.
Table 1
Selected Characteristics of Studies Comparating Different Types of Psychotherapy for Depression in Specific Target Populations
Target group Recr Depression Conditions N Nsess Form Risk of biasa C
Alexopoulos, 2003 Older adults with
executive dysfunction




12 Ind − − + + US
Arean, 2010 Older adults with
executive dysfunction




12 Ind − − + + US




12 Grp − − + − US




16 Ind + + − − US




12 Grp − − − − EU






20 Ind − − − − US










− − − + US




8 Grp − − sr − US






16 Ind − − − − US




10 Grp − − sr − US




20 Ind + − − − US




15 Ind − − + + EU




12 Ind + − + − US




12 Grp + − sr + US
Hogg, 1988 Students Clin SR 1. CBT
2. Interp grp ther
13
14
8 Grp − − sr − US




8 Ind + − − + US









− + + + AU




8 Grp − − sr − US
Kiosses, 2010 Cognitively impaired
disabled elders




12 Ind − − + + US




12 Ind − − − + CA




20 Ind − − + + EU
Manicavasgar, 2010 Nonmelancholic
depression




6 Grp − − − − AU






16 Ind + + + + US




17 Ind + − + + US
Markowitz, 2008 Dysthymia and alcohol
problems




17 Ind + − + + US
(continued on next page)
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Table 1 (continued)
Target group Recr Depression Conditions N Nsess Form Risk of biasa C









+ + + + US






− − − + US




16 Tel − − + + US
Mondin, 2014 Young adults Comm Mood 1. CBT
2. Cogn narr ther
60
60
7 Ind − + + − Bra
Padfield, 1976 Rural women of low
socioeconomic status




12 Ind − − − − US




4 Grp − − sr − US
Rovner, 2014 Age-related macular
degeneration




6 Ind + + + − US
Schramm, 2010 Early-onset chronic
depression




22 Ind + + + − EU






8 Grp − − + − US




6 Ind − − sr + CA




9 Ind − − + − US






18 Ind − − − − US






18 Ind − − − − US




8 Ind + − − + EU
Verduyn, 2003 Mothers of young
children




16 Grp − + + − EU




12 Grp − − + − US
Note. References of the included studies are listed in the Appendix.
AU = Australia; BAT = behavioral activation therapy; Bra = Brazil; C = country; CA = Canada; CBASP = cognitive-behavioral analysis system
of psychotherapy; CBT = cognitive-behavioral therapy; cCBT = computerized cognitive-behavioral therapy; Clin = recruitment from clinical
samples; Cogn = cognitive; Comm = recruitment from community samples; DYN = psychodynamic therapy; EU = Europe; Form = format;
Grp = group; Ind = individual; Interp = interpersonal; IPT = interpersonal psychotherapy; MBCT = mindfulness-based cognitive therapy;
MDD = major depression; MI = motivational interviewing; Mood = mood disorder; MS = multiple sclerosis; Narr = narrative; Nsess = number
of sessions; PPD = postpartum depression; Prescr = prescriptive; PST = problem-solving therapy; Recr = recruitment; SR = self-report;
SUP = nondirective supportive counseling; Tel = telephone; Ther = therapy; US = United States.
a In this column a positive (+) or negative (–) sign is given for four quality criteria, respectively: allocation sequence, concealment of
allocation to conditions, blinding of assessors, and intention-to-treat analyses. Sr indicates that only self-report measures were used.
972 cu i j p er s e t al .quality criteria. Seven studies (17%) met three or
four of the criteria and are considered in the rest of
this paper as having low risk of bias.
cbt versus other psychotherapies
We identified 16 patient characteristics that were
examined in comparative outcome studies of CBT
versus other psychotherapies (Table 2). We found
that CBTwas significantly more effective than other
therapies in older adults (N55 years, g = 0.29),university students (g = 0.51), when patients also had
an addiction problem (g = 0.31), in multiple sclerosis
patients (g = 0.42), in women in their menopause
(g = 1.56), and in young adults (18–29 years, g =
0.59). As sensitivity analyses we limited the anal-
yses to studies with low risk of bias. We found that
none of the characteristics remained significant
(Table 3). In another series of sensitivity analyses
we limited the analyses to those characteristics with
four or more comparisons (and therefore having
Table 2
Comparative Studies of Psychotherapies for Specific Target Populations: Hedges’s ga
Ncomp g 95% CI I
2
CBT versus other therapies
Type of depression • Postpartum depression 2 -0.16 -0.46~0.15 0 -
• Nonmelancholic 1 -0.15 -0.73~0.43 0
Sociodemographic • Older adults 7 0.29 0.01~0.56 0 0~58
• Women 1 -0.43 -1.26~0.40 0
• Women in menopause 1 1.56 0.74~2.37 0
• Young adults 1 0.59 0.10~1.08 0
Comorbid conditions • Addictive problems 4 0.31 0.01~0.62 0 0~68
• HIV 3 -0.33 -0.66~0.00 0 -
• MS patients 2 0.42 0.11~0.73 0
• Cancer 1 -0.16 -0.72~0.40 0 -
• Diabetes in pregnancy 1 0.41 -0.26~1.09 0 -
• Diabetes 1 0 -0.49~0.49 0 -
• Traumatic brain injury 1 0.04 -0.51~0.60 0
Other • Students 5 0.46 0.05~0.88 23 0~76
• Mothers of young children 1 0.06 -0.44~0.57 0 -
• Family caregivers 1 0.41 -0.60~1.42 0 -
Nondirective counseling versus other therapies
Type of depression • Dysthymia 1 -0.05 -0.60~0.50 0 -
• Dysth + alcohol problems 1 -0.62 -1.40~0.15 0 -
• Minor depression 1 -0.03 -0.87~0.81 0 -
• Nonmelancholic depression 1 -0.15 -0.73~0.43 0 -
Sociodemographic • Low-inc homeb. elderly 2 -0.68 -1.02~-0.34 0 -
• Mothers of young children 1 -0.06 -0.57~0.44 0 -
• Older adults 1 -0.45 -0.99~0.09 0 -
• Rural women of low SES 1 -0.69 -1.49~0.11 0 -
Comorbid conditions • Addictive disorders 2 -0.27 -0.62~0.08 0 -
• Cancer patients 1 0.16 -0.40~0.72 0 -
• Cogn. imp. disabled elders 1 -0.75 -1.54~0.04 0 -
• Diabetes in pregnancy 1 -0.41 -1.09~0.26 0 -
• HIV patients 5 -0.02 -0.22~0.18 33 0~75
• Age-rel. macular degen. 1 -0.35 -0.79~0.10 0 -
• Traumatic brain injury 1 -0.04 -0.60~0.51 0 -
Other • Infertile women 1 -0.61 -1.31~0.09 0 -
• Students 3 -0.78 -1.21~-0.34 0 0~73
• Women in menopause 1 -1.56 -2.37~-0.74 0 -
PST versus other therapies
Sociodemographic • Older adults with exec. dysf. 3 0.49 0.24~0.75 28 0~80
• Low-income homeb. elderly 2 0.68 0.34~1.02 0 -
• Older adults 1 0.52 -0.07~1.11 0 -
Comorbid conditions • Dementia patients 1 -0.37 -0.98~0.23 0 -
• Breast cancer patients 1 -0.01 -0.44~0.43 0 -
IPT versus other therapies
• Dysthymia 1 0.05 -0.50~0.60 0 -
• Dyst. + alcohol problems 1 0.62 -0.15~1.40 0 -
• HIV patients 2 0.51 0.12~0.91 0 -
• Infertile women 1 0.61 -0.09~1.31 0 -
Psychodynamic versus other therapies
• Older adults 4 -0.21 -0.57~0.15 0 -
• Family caregivers 1 -0.41 -1.42~0.60 0 -
• Minor depression 1 0.03 -0.81~0.87 0 -
Behavioral activation versus other therapies
• Older adults 6 0.07 -0.24~0.37 0 0~61
• Students 2 -0.59 -1.29~0.11 35 -
(continued on next page)
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Table 2 (continued)
Ncomp g 95% CI I
2
• Breast cancer patients 1 0.01 -0.43~0.44 0 -
• Dementia patients 1 0.00 -0.61~0.60 0 -
• Rural women of low SES 1 0.69 -0.11~1.49 0 -
Note. Underlined values for g are significantly different from zero. Age-rel = age-related; CBT = cognitive-behavioral therapy; CI =
confidence interval; Cogn imp = cognitive impairment; Degen = degenerative; Dyst = dysthymia; Exec dysf = executive dysfunction; HIV =
human immunodeficiency virus; Homeb = homebound; IPT = interpersonal therapy; Low inc = low income; MS = multiple sclerosis; Ncomp =
number of comparisons; PST = problem-solving therapy; SES = socioeconomic status.
a According to the random effects model.
Behavioral activation versus other therapies
974 cu i j p er s e t al .sufficient power for finding an effect size of g =
0.50, see below). We have reported the alternative
psychotherapy against which CBT was compared
in Table 4. As can be seen in these comparisons
only the CBT versus behavioral activation therapy
in university students remained significant (g = 0.71
in favor of CBT).
The average number of patients per condition
was 30, and our power calculations indicated that
we would need 4 studies per characteristic to find
an effect size of g = 0.50 (a total of 64 studies for the
16 characteristics) and 16 studies per characteristic
to find an effect size of g = 0.24 (256 studies for theTable 3
Comparative Studies of Psychotherapies for Specific Target
Populations With Low Risk of Bias: Hedges’s ga,b
Ncomp g 95% CI I
2
CBT versus other therapies
• Addictive disorders 2 0.27 -0.08~0.62 0
• HIV patients 2 -0.31 -0.70~0.08 29
• PPD 2 -0.16 -0.46~0.15 0
• Traumatic brain injury 1 0.04 -0.51~0.60 0
Nondirective counseling versus other therapies
• HIV patients 3 -0.12 -0.34~0.11 5c
• Addictive disorders 2 -0.27 -0.62~0.08 0
• Age-rel macul degeneration 1 -0.35 -0.79~0.10 0
• Dysthymia 1 -0.05 -0.60~0.50 0
• Dysthymia + alc. problems 1 -0.62 -1.40~0.15 0
• Traumatic brain injury 1 -0.04 -0.60~0.51 0
IPT versus other therapies
• Dysthymia 1 0.05 -0.50~0.60 0
• Dysthymia + alc. problems 1 0.62 -0.15~1.40 0
• HIV patients 2 0.51 0.12~0.91 0
Note. Age-rel = age-related; Alc = alcohol; CBT = cognitive-
behavioral therapy; CI = confidence interval; HIV = human
immunodeficiency virus; IPT = interpersonal therapy; Macul =
macular; Ncomp = number of comparisons; PPD = postpartum
depression.
a According to the random effects model.
b No studies on problem-solving, behavioral activation, and
psychodynamic therapies had low risk of bias
c The 95% CI of this value for I2 is 0~74. For the other values
of I 2 in this table the 95% CI cannot be calculated because the
number of studies was too small.16 characteristics). Overall, we had 34 comparisons
(53% of the studies needed to show an effect size
of g = 0.50, and 13% of the studies when we used
g = 0.24). Only 7 comparisons had a low risk of
bias, which was 11% of the studies needed to
show an effect of g = 0.50, and 3% for an effect size
of g = 0.24.
ndst versus other psychotherapies
NDST was examined in 17 specific target popula-
tions (Table 3). NDST was significantly less effec-
tive than other therapies in low-income homebound
elderly (g = –0.68), in students (g = –0.78), and in
menopausal women (g = –1.56). When we looked
only at the studies with low risk of bias, none of the
outcomes was significant.
For the 17 characteristics examined in these studies,
72 comparisons are needed to find an effect size of g =
0.50, (4 per characteristic) and 272 studies to find an
effect size of g = 0.24. The 26 comparisons we had
was 36% of the studies needed to show an effect size
of g = 0.50 and 10% of the studies for showing g =
0.24.Only 9 comparisons had a low risk of bias (13%
of the studies needed to show an effect of g = 0.50 and






and behavioral activation therapy were examined
in eight, four, three, and six specific target groups,
respectively (Table 2). We found that PST was more
effective than other therapies in older adults with
executive dysfunctions (g = 0.49) and in low-
income homebound elderly (g = 0.68), and IPT was
more effective than other therapies in HIV patients
(g = 0.51).
When we looked only at the four studies with low
risk of bias examining IPT, none of the outcomes for
specific target groups remained statistically significant.
No studies on PST, behavioral activation therapy, and
psychodynamic therapies had low risk of bias.
Table 4
Comparative Outcome Studies for Adult Depression in Specific Target Groups With More Than Four Comparisonsa
Ncomp g 95% CI I
2 95% CI P b
CBT versus other therapies
Older adults • Behavioral activation 2 0.07 -0.45~0.58 0 c 0.73
• Psychodynamic therapy 3 0.38 -0.07~0.83 0 0~73
• NDST 1 0.45 -0.10~1.00 0 c
• Other therapy 1 0.18 -0.66~1.02 0 c
Students • Behavioral activation 3 0.71 0.13~1.30 2 0~73 0.12
• NDST 1 0.90 -0.09~1.88 1 c
• Other therapy 1 -0.17 -0.92~0.57 1 c
Addictive disorders • NDST 2 0.27 -0.08~0.62 0 c 0.63
• Other therapy 2 0.45 -0.19~1.09 0 c
Note. CBT = cognitive-behavioral therapy; CI = confidence interval; Ncomp = number of comparisons; NDST = nondirective supportive
therapy.
a According to the random effects model.
b The p values in this column indicate whether the difference between the effect sizes in the subgroups is significant.
c Confidence intervals around I2 cannot be calculated if there are fewer than three groups.
975per sonal i zed therapy for depre s s ionThe five characteristics examined for PST were
examined in eight studies (40%of the studies needed
to show an effect size of g = 0.50 and 10% of the
studies needed to show an effect size of g = 0.24).
The four characteristics for IPTwere examined in six
studies (38% of the studies needed to find g = 0.50
and 9% of the studies needed to find g = 0.24). The
three characteristics examined for psychodynamic
therapy were examined in six studies (50% of the
studies needed to show g = 0.50 and 13% of the
studies to show g = 0.24). Finally, behavioral acti-
vation therapy was examined in 11 studies of five
specific target groups (55% of the studies needed to
show an effect size of g = 0.50 and 14%of the studies
needed to show g = 0.24).
overall outcomes
When we limit the outcomes to the comparisons
with sufficient power to find an effect size of g = 0.50
(number of studies N 4) and which were significant,
only three specific target groups remained. CBTwas
more effective than other psychotherapies in older
adults, in patients with comorbid alcohol problems,
and in university students. Several of the studies on
which these outcomes were based had a high risk of
bias, so these results should also be considered with
caution.
The 41 studies examined a total of 27 character-
istics. In order to examine whether these six types
of psychotherapy were more effective than other
therapies we would need a total of 648 studies to
find an effect size of g = 0.50, and 2,592 studies to
find an effect size of g = 0.24. The 41 studies that
have been conducted to examine these specific
target groups are 6% of the studies needed to find
an effect size of g = 0.50 and 2% of the studies
needed to find an effect size of g = 0.24. Only 7studies had low risk of bias, which is 1% of the
studies needed to show an effect size of g = 0.05,
and 0.2% of the studies needed to show an effect
size of g = 0.24. The number of studies needed
would increase exponentially if we would examine
the contrast between each of the specific therapies,
so not CBT versus all psychotherapies, but only
CBT versus IPT, CBT versus PST, and so on.
Since the year 2000, 26 studies were conducted
(1.86 study per year). If the number of studies will
be conducted at the same rate in the future, it will
take 326 years before all of these 27 characteristics
have been examined with sufficient power to find
an effect size of g = 0.50 and 1,372 years for an
effect size of g = 0.24, assuming that all new studies
have a low risk of bias.
Discussion
If we want to build the development of personalized
treatments on the gold standard of evidence-based
health care, the randomized trial, it is important to
examine whether one treatment is more effective
than another treatment in a specific subgroup of
patients. We conducted a systematic review and
meta-analysis of randomized trials comparing two
psychotherapies directly in subgroups of depressed
adults. We focused on the six best examined types
of psychotherapy for adult depression. We found
that 27 characteristics of patients had been
examined in 41 trials. However, only for a few
characteristics was sufficient statistical power
available to show a clinically relevant effect size
(of g = 0.50). CBT was found to be more effective
than other therapies in older adults (g = 0.29), in
patients with comorbid addictive disorders (g =
0.31), and in university students (g = 0.46). For
none of the other therapies did we find
976 cu i j p er s e t al .characteristics that had sufficient statistical power
to show that one therapy was more effective than
another therapy. When we used a more conserva-
tive estimate of clinical relevance, there was not
sufficient power for any of the 27 characteristics.
From a clinical point of view it is worth noting
that CBT stands out as being superior in at least
three samples (older adults, patients with comorbid
addictive disorders, and university students). Even
if we would need larger studies and more charac-
teristics to conclude that CBT is more effective
than other psychotherapies overall, and this finding
would contrast with most (e.g., Cuijpers et al.,
2013; Marcus, O’Connell, Norris, & Sawaqdeh,
2014; Wampold, Minami, Baskin, & Callen
Tierney, 2002), but not all (Tolin, 2010), previous
meta-analytic findings in the depression literature,
it is still possible that CBT is slightly more effective
in certain subgroups.
A disturbing finding was that only 7 of the 41
studies had low risk of bias. That means that in the
large majority of studies there is a considerable
chance that the findings are biased. This is in line
with earlier meta-analytic research showing that the
risk of bias is high in studies on psychotherapies for
adult depression (Cuijpers, van Straten, Bohlmeijer,
Hollon, & Andersson, 2010). It is important to
note that in this earlier meta-analysis it was found
that studies with high risk of bias had considerably
higher effect sizes than studies with low risk of bias.
This has probably influenced the outcomes of the
current meta-analysis as well.
This meta-analysis also suggests that examining
the comparative effects of different psychotherapies
in specific target groups is probably not the most
efficient way to develop personalized treatments.
We calculated that if we continue to do randomized
comparative outcome studies at the same rate as
they have been done in recent years, it will take
more than 300 years to examine the 27 character-
istics in the 7 psychotherapies when a liberal thresh-
old for clinical relevance is taken and more than
1,300 years when amore stringent threshold is used.
Clearly this is not a feasible approach.
In recent years, several other techniques have
been used to develop personalized treatments of
mental health problems. In a more comprehensive
review of these techniques (Cuijpers, 2014), we
have described that some studies have used data-
mining techniques in large samples of patients to
develop decision trees for defining what the best
treatment is for a specific patient (Jain et al., 2013;
Rabinoff et al., 2011; Riedel et al., 2011). Clinical
staging has also been proposed as a framework for
developing personalized treatments for depression,
but unfortunately there is very little evidence at thismoment that clinical staging results in better out-
comes (Cuijpers, 2014).Othermethods have focused
on integrating the results of different predictors of
outcome into one estimate of the best treatment for
a specific patient (DeRubeis et al., 2014; Kraemer,
2013). Although these approaches cannot be based
on the scientific strength of the experimental design
of randomized trials (like the trials included in this
review), these approaches seem much more feasible
than focusing on comparative outcome trials in
specific patient subpopulations. And these studies
can be used to generate prediction algorithms, which
could then be tested in randomized trials.
It has also been suggested that if we want to
develop personalized treatments formental disorders,
these analyses should be based on the individual, not
the group (Molenaar, 2004; Molenaar & Campbell,
2009). Such methods hold promise and provide
a completely new way of thinking about mental
disorders and their treatment. They may provide a
better way of developing personalized treatments
than the approach described in this paper; however,
randomized trials showing that these methods indeed
result in better outcomes are still needed.
This systematic review has several strengths and
limitations; some have been described already. The
studies examined in this review are not the only
type of studies that result in relevant information
about specific treatments for specific target popu-
lations. However, the trials we reviewed do result in
the best available evidence, as they are based on
randomized trials and not on secondary post hoc
analyses of earlier trials. Although the number of
studies was relatively large, many more are needed
before we actually are capable of personalizing
treatments for adult depression, and it may take
hundreds of years before a relatively small set of
predictors have been examined with sufficient sta-
tistical power. A problem with the current set of
studies was that the risk of bias in the included
studies was considerable, and only a selected num-
ber of potentially relevant moderators were exam-
ined. It should also be stated as a limitation that the
characteristics we selected in this study were not
theoretically based or empirically derived, but were
only selected because there were enough clinical
trials available that examined them. Another prob-
lem with the current studies is that in most trials the
standard manuals of the treatment were adapted
for use with the specific target group in the study.
When the effect sizes found in these studies are
different from those found in generic trials, it is
impossible to know whether these differences are
caused by the adapted manuals or by the different
characteristics of the target group. Furthermore,
we only examined short-term outcomes, whereas
977per sonal i zed therapy for depre s s ionlonger-term outcomes may be more relevant from a
clinical point of view.
Personalized treatment of depression is one of
the most important challenges for mental health
researchers in the next decades. Although several
dozens of comparative outcome studies in sub-
populations have been conducted, this seems not
the best way to develop personalized treatments for
adult depression.
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